| View |
|
DRP-13825-01
|
Multivitamins + Minerals
|
Trigobion
|
(see reverse for formulation)
|
Capsule
|
Vitamins/Minerals
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
21 May 2024
|
27 April 2025
|
| View |
|
DRP-14029-02
|
Pantoprazole (as sodium sesquihydrate) + Domperidone (as maleate)
|
Domperaz
|
40 mg/30 mg
|
Modified Release Capsule
|
Proton Pump Inhibitor/Propulsive
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
21 May 2024
|
07 June 2028
|
| View |
|
DRP-14205-01
|
Sugammadex (as sodium)
|
Sugatam
|
100 mg/mL
|
Solution for Injection (I.V.)
|
Antidote
|
Mankind Pharma Limited (Unit III)
|
India
|
CLIDP Conversion
|
20 May 2024
|
21 July 2028
|
| View |
|
DRP-14208-02
|
Pantoprazole (as sodium)
|
Gosec
|
40 mg
|
Enteric-Coated Tablet
|
'-'
|
Ratnatris Pharmaceuticals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
19 May 2024
|
21 July 2028
|
| View |
|
DRP-1425-17
|
Amoxicillin (as Trihydrate)
|
None
|
250 mg/5 mL
|
Powder for Suspension
|
Antibacterial (Penicillin)
|
J.M. Tolmann Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
21 May 2024
|
21 November 2026
|
| View |
|
DRP-14375-04
|
Dutasteride + Tamsulosin Hydrochloride
|
Tamsukem-D
|
500 mcg / 400 mcg
|
Capsule
|
Benign Prostatic Hypertrophy Drug (Alpha-Adrenoreceptor Antagonist)
|
Pell Tech Health Care Private Ltd.
|
India
|
CLIDP Conversion
|
19 May 2024
|
31 August 2028
|
| View |
|
DRP-14400-01
|
Ertapenem (as sodium)
|
Ertax
|
1g
|
Lyophilized Powder for Injection (I.M./I.V. Infusion)
|
Antibacterial (Carbapenem Beta-lactam)
|
CSPC Ouyi Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
19 May 2024
|
05 September 2028
|
| View |
|
DRP-1456-06
|
Losartan Potassium
|
LosaSpeed 50
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Interphil Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
20 May 2024
|
19 March 2029
|
| View |
|
DRP-14687-01
|
Losartan Potassium + Amlodipine (as besilate)
|
Tozam 100/10
|
100 mg / 10 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blockers (ARB) / Calcium Channel Blocker
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
21 May 2024
|
23 November 2028
|
| View |
|
DRP-14776-03
|
Norepinephrine (as bitartrate)
|
Quinor 8
|
2 mg/mL (8 mg/4 mL)
|
Solution for Injection (I.V. Infusion)
|
Adrenergic/ Dopaminergic Agent
|
Ultra Laboratories Private Limited
|
India
|
CLIDP Conversion
|
21 May 2024
|
03 January 2029
|
| View |
|
DRP-14777-03
|
Norepinephrine (as bitartrate)
|
Quinor 4
|
1 mg/mL (4 mg/4 mL)
|
Solution for Injection (I.V. Infusion)
|
Adrenergic/ Dopaminergic Agent
|
Ultra Laboratories Private Limited
|
India
|
CLIDP Conversion
|
19 May 2024
|
03 January 2029
|
| View |
|
DRP-14809-01
|
Omeprazole
|
Omephil 40
|
40 mg
|
Delayed-Release Capsule
|
Proton Pump Inhibitor
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
19 May 2024
|
26 February 2029
|
| View |
|
DRP-1651-4
|
Folic Acid
|
Flovomed
|
5 mg
|
Tablet
|
Vitamin/Hematinic
|
LIFESQUARE LABORATORIES INC.
|
Philippines
|
CLIDP Conversion
|
17 May 2024
|
25 September 2029
|
| View |
|
DRP-2254-04
|
Atorvastatin (as calcium)
|
Gostat 40
|
40 mg
|
Film-Coated Tablet
|
HMG CoA Reductase Inhibitor
|
Umedica Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
20 May 2024
|
09 June 2025
|
| View |
|
DRP-2365-01
|
Oxaliplatin
|
Colorebene
|
50 mg
|
Lyophilized Powder for Solution for I.V. Infusion
|
Antineoplastic
|
Celon Laboratories Private Limited
|
India
|
CLIDP Conversion
|
21 May 2024
|
30 July 2025
|
| View |
|
DRP-3037-03
|
Montelukast (as sodium)
|
Mediair-chews
|
5 mg
|
Chewable Tablet
|
Leukotriene Receptor Antagonist
|
Maple Pharmaceuticals (Pvt.) Ltd.
|
Pakistan
|
CLIDP Conversion
|
16 May 2024
|
26 June 2027
|
| View |
|
DRP-3322-08
|
Azithromycin (as dihydrate)
|
Strozin
|
200 mg/5mL
|
Powder for Suspension
|
Antibacterial (Macrolide)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
16 May 2024
|
08 July 2029
|
| View |
|
DRP-3915-03
|
Candesartan Cilexetil
|
None
|
8 mg
|
Tablet
|
Angiotensin II Antagonists
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
21 May 2024
|
14 August 2027
|
| View |
|
DRP-3916-03
|
Candesartan Cilexetil
|
None
|
16 mg
|
Tablet
|
Angiotensin II Antagonist
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
21 May 2024
|
14 August 2027
|
| View |
|
DRP-4403-02
|
Simvastatin
|
None
|
20 mg
|
Film-Coated Tablet
|
HMG-CoA Reductase Inhibitor
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
CLIDP Conversion
|
19 May 2024
|
02 May 2028
|